APPLICATIONS PUBLISHED 23 APRIL 2003
Published: 1-Oct-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Pharmaceutical extemporary compsns
The Boots Company 1303257*
Novel aerosol formulation containing a polar fluorinated molecule
AstraZeneca 1303258*
Prolonged release microspheres for injection delivery and preparation method
Mainelab 1303259*
Linkage of agents using microparticles
Pericor Science 1303260*
Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
Pharmacia & Upjohn 1303261*
Use of a SPLA2 inhibitor for the treatment of sepsis
Eli Lilly 1303262*
Antibacterial method and compsn with phenolic compounds
Colgate-Palmolive 1303263*
Compsns and methods for treating cardiovascular disorders
The Heart Research Institute 1303264*
Use of COX-2 inhibitors for preventing immunodeficiency
Lauras 1303265*
Treatment of eating disorders using carboxyalkylethers
Warner-Lambert 1303266*
Dermal for amino laevulinic acid
Medac Gesellschaft fuer klinische Spezialpraeparate 1303267*
Highly purified simvastatin compsns
Plus Chemicals 1303268*
Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
NeuroSearch 1303269*
Method for treating cryptorchidism
Hormos Medical Corp 1303270*
Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
Pharmacia & Upjohn 1303271*
Benzothiole derivatives
F Hoffmann-La Roche 1303272*
New pharmaceutical compsn and the process for its preparation
Novo Nordisk 1303273*
Method of promoting smoking cessation
Research Triangle Institute 1303274*
Paroxetine tablets and capsules
Pentech Pharmaceuticals 1303275*
A bioavailable dosage form of loratidine
Ranbaxy Laboratories 1303276*
Pharmaceutical compsn based on cocaethylene and use thereof for treating psychoactive substance dependence
Dubussy Holding 1303277*
Combination of a transdermal system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
NeuroBiotec 1303278*
Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
Wood, Ralph 1303279*
Enhanced brain function by GABA-ergic stimulation
University of Utah Research Foundation 1303280*
Methods of treatment
SmithKline Beecham 1303281*
Pyrido(2,3-D)pyrimidine and pyrimido(4,5-D)pyrimidine nucleosides
Ribapharm 1303282*
Treatment of hyperproliferative skin disorders and diseases
Nucryst Pharmaceuticals 1303283*
Compsns and methods for the treatment of skin damage
GroPep 1303284*
Methods and formulations with probiotic micro-oganisms and medicaments
Chr. Hansen A/S 1303285*
Use of strains of the Parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
Bayer 1303286*
MHC peptides over-expressed on prostate cancer cells and methods of use
Argonex Pharmaceuticals 1303287*
Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-alpha inhibitors
Natimmune 1303288*
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mani in bipolar disorder
Teva Pharmaceutical Industries 1303289*
Small peptides and methods for down regulation of IGE
Histatek 1303290*
Anti-HIV and anti-tumour peptides and fragments of lysosome
New York University 1303291*
Chemokine conjugates
SmithKline Beecham 1303292*
APO-2L receptor agonist and CPT-11 synergism
Genentech 1303293*
Method for treating unstable angina pectoris
ZLB Bioplasma 1303294*
Agent for inhibiting adhesion of the pathogenic flora of the skin
Societe des Produits Nestle 1303295*
Compsn containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof
Isocell 1303296*
Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
SanguiBioTech 1303297*
Pharmaceutical compsn comprising carriers for products based on vitamin E, papain and hyaluronidase
Topic Empreendimentos e Participacoes 1303298*
Compsns and methods for enhancing immunogenicity of antigens
The Trustees of the University of Pennsylvania 1303299*
Compsns and methods for treatment of candiasis
Candivax 1303300*
Preventing airway mucus production by administration of EGF-R antagonists
The Regents of the University of California 1303301*
Use of strains of the papavox ovis virus against organ fibrosis
Bayer 1303302*
Immunomodulatory human MHC class II antigen-bonding
GPC Biotech; MorphoSys 1303303*
Pharmaceutical combinations for treatment for treatment and prevention of diabetes mellitus
Keri Pharma 1303304*
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
Pharmacia 1303305*
Epoxy-steroidal aldosterone and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
Pharmacia 1303306*
Combined therapy against tumours comprising substituted acryloyl ditsamycin derivatives and alkylating agents
Pharmacia Italia 1303307*
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
Pharmacia 1303308*
Rapidly-disintegrating tablets for animals
Commonwealth Scientific and Industrial Research Organisation 1303309*
Use of the interferon receptor 2C polypeptide chain to enhance the anti-growth effects of type 1 interferons
Schering 1303310*
Amyloid targeting imaging agents and uses thereof
Neurochem 1303311*
Diagnosis of liver disease
BTG International 1303312*
Meted hyperpolarised noble gas dispensing methods and associated devices
Medi-Physics 1303313*
